This inventor holds 1 USPTO granted patent. Top assignee: Alpha Therapeutic Corporation. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Yahiro (Roy) Uemura: Innovator in Protein Purification
Introduction
Yahiro (Roy) Uemura is a notable inventor based in Arcadia, CA (US). He has made significant contributions to the field of protein purification, particularly through his innovative processes. His work has implications for various applications in biotechnology and pharmaceuticals.
Latest Patents
Uemura holds a patent for a process titled "Process for separating α1-proteinase inhibitor from Cohn fraction IV1 and IV4 paste." This invention focuses on purifying α1-proteinase inhibitor, which is crucial for various therapeutic applications. The process involves precipitating an impure protein fraction with polyethylene glycol (PEG), followed by anion-exchange and metal chelate mediums to recover the purified protein. The resulting α1-proteinase inhibitor exhibits a specific activity greater than 0.6 units/mg, showcasing the effectiveness of Uemura's method.
Career Highlights
Uemura is associated with Alpha Therapeutic Corporation, where he applies his expertise in protein purification. His work at the company has contributed to advancements in therapeutic protein production. Uemura's innovative approach has positioned him as a valuable asset in the biotechnology sector.
Collaborations
Uemura has collaborated with notable colleagues, including T (Tom) Taniguchi and John Mark Rolf. These collaborations have fostered a productive environment for innovation and research within the company.
Conclusion
Yahiro (Roy) Uemura's contributions to protein purification highlight his role as an innovator in the biotechnology field. His patented processes and collaborations demonstrate his commitment to advancing therapeutic solutions. Uemura's work continues to impact the industry positively.